These findings align with preclinical studies showing that 5-HT4R activation can alleviate cognitive deficits and exert rapid anxiolytic effects in rodent models of major depression, Alzheimer’s disease, and Parkinson’s disease [10,12,14,41,42]. The gene discussed is HTR4; the disease is early-onset autosomal dominant Alzheimer disease.